Healthcare Sustainability Blog Page Image

sustainability in healthcare

Minimising Healthcare’s Contribution to Climate Change through Innovation 

Download our whitepaper

Ready for Net Negative?


Medical device developers and pharmaceutical companies are starting to take sustainability seriously, but by focusing only on their own Scope 1, 2, and 3 emissions they significantly limit the overall impact their products can have across healthcare, which is responsible for almost 5% of global carbon emissions.

In this whitepaper, 'Ready for Net Negative?', we offer a new perspective to enable a step change in reducing the environmental impact of healthcare. Consideration of sustainability impacts at the level of the care pathway together with innovation will allow industry leaders to deliver net-negative products and services – without the use of emissions off-setting.

Healthcare Sustainability Landing Page Image

Access the whitepaper

In 'Ready for Net Negative?', we cover the following topics:

  • How sustainability targets are currently set and met within business
  • How suppliers to healthcare systems can ask the right questions to achieve the greatest possible reduction in carbon emissions with their products
  • How to reduce direct and indirect emissions at the level of the care pathway  
  • How digital health can catalyse a shift to more sustainable healthcare

We also provide two detailed case studies of an at-home diagnostic device and of minimally invasive surgery to illustrate the wealth of opportunities to improve the quality of care while minimising the contribution to climate change.


Experts from across TTP’s Healthcare technology teams contributed to this white paper. Freddie Scott and Adam Bostanci posed the question "How can we improve the quality of healthcare while achieving the greatest possible net reduction in associated carbon emissions?", and Freddie Scott answered it for medical devices. Rita Stella explored an area with huge potential to benefit patients and reduce climate impact: minimally invasive surgery. Karthik Chellappan, Clennell Collingwood, Nathan Wilkinson, and Simon Lyons focused on what the approach would mean for pharma and digital health.

Get in touch

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.